Alivus Life Sciences Q1 Results
- BSE: 543322
- NSE: ALIVUS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
1,309.15
-34.00 (-2.53%)
-34.00 (-2.53%)Volume2.36 K
Updated: Fri 16 Oct, 2026 | 15:55:17
NSE
1,309-32.80 (-2.44%)
-32.80 (-2.44%)Volume35.95 K
Updated: Fri 16 Oct, 2026 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹640.41 Cr.(6.41%)
- Operating Profit₹191.13 Cr.(23.11%)
- Profit After Tax₹160.08 Cr.(31.71%)
- Operating Margin29.84%(15.70%)
Note: Comparison is on YoY basis
Quarterly - Alivus Life Sciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 449.29 | 494.79 | -9.20% | 443.52 | 0.60% |
| Depreciation/ Amortization | 20.59 | 20.20 | 1.91% | 14.39 | 20.63% |
| Operating Income | 191.13 | 194.33 | -1.65% | 145.10 | 23.11% |
| Net Income | 160.08 | 162.66 | -1.59% | 111.48 | 31.71% |
| Other Operating Expenses Total | 105.41 | 125.62 | -16.09% | 84.50 | 8.03% |
| Net Income Before Taxes | 212.22 | 215.80 | -1.66% | 150.24 | 30.21% |
| Total Revenue | 640.41 | 689.12 | -7.07% | 588.62 | 6.41% |
| Selling/ General/ Admin Expenses Total | 68.25 | 78.12 | -12.64% | 56.84 | 10.83% |
| Diluted Normalized EPS | 13.01 | 13.22 | -1.59% | 9.08 | 31.68% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.